Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.12 Million USD | 1416.53% |
| 2022 | 1.19 Million USD | 113.84% |
| 2021 | -8.63 Million USD | 25.22% |
| 2020 | -11.55 Million USD | -1111.9% |
| 2019 | -953.2 Thousand USD | 76.68% |
| 2018 | -4.08 Million USD | -177.01% |
| 2017 | 5.3 Million USD | -0.58% |
| 2016 | 5.33 Million USD | 1329.9% |
| 2015 | -434 Thousand USD | -118.97% |
| 2014 | 2.28 Million USD | -33.35% |
| 2013 | 3.43 Million USD | -3.68% |
| 2012 | 3.56 Million USD | 2.85% |
| 2011 | 3.46 Million USD | -37.76% |
| 2010 | 5.56 Million USD | 52.17% |
| 2009 | 3.65 Million USD | 461.2% |
| 2008 | -1.01 Million USD | 38.72% |
| 2007 | -1.65 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 17.03 Million USD | -13.05% |
| 2024 Q1 | 19.59 Million USD | 8.08% |
| 2023 Q2 | 3.42 Million USD | 77.58% |
| 2023 Q1 | 1.92 Million USD | 61.17% |
| 2023 Q4 | 18.12 Million USD | 166.39% |
| 2023 Q3 | 6.8 Million USD | 98.91% |
| 2023 FY | 18.12 Million USD | 1416.53% |
| 2022 FY | 1.19 Million USD | 113.84% |
| 2022 Q2 | -7.91 Million USD | 8.29% |
| 2022 Q3 | -6.8 Million USD | 14.04% |
| 2022 Q4 | 1.19 Million USD | 117.57% |
| 2022 Q1 | -8.62 Million USD | 0.14% |
| 2021 Q3 | -6.66 Million USD | 46.28% |
| 2021 Q2 | -12.41 Million USD | -2.79% |
| 2021 Q1 | -12.07 Million USD | -4.55% |
| 2021 FY | -8.63 Million USD | 25.22% |
| 2021 Q4 | -8.63 Million USD | -29.54% |
| 2020 Q1 | -1.01 Million USD | -6.13% |
| 2020 FY | -11.55 Million USD | -1111.9% |
| 2020 Q2 | -6.11 Million USD | -504.19% |
| 2020 Q3 | -8.51 Million USD | -39.33% |
| 2020 Q4 | -11.55 Million USD | -35.65% |
| 2019 Q1 | -2.85 Million USD | 30.21% |
| 2019 Q2 | -3.26 Million USD | -14.51% |
| 2019 Q4 | -953.2 Thousand USD | -134.5% |
| 2019 FY | -953.2 Thousand USD | 76.68% |
| 2019 Q3 | 2.76 Million USD | 184.58% |
| 2018 Q1 | 4.93 Million USD | -7.06% |
| 2018 Q4 | -4.08 Million USD | -47.37% |
| 2018 FY | -4.08 Million USD | -177.01% |
| 2018 Q3 | -2.77 Million USD | -169.65% |
| 2018 Q2 | 3.98 Million USD | -19.27% |
| 2017 Q1 | 4.17 Million USD | -21.84% |
| 2017 Q4 | 5.3 Million USD | -12.14% |
| 2017 FY | 5.3 Million USD | -0.58% |
| 2017 Q3 | 6.04 Million USD | -5.05% |
| 2017 Q2 | 6.36 Million USD | 52.47% |
| 2016 Q1 | -624.09 Thousand USD | -43.8% |
| 2016 FY | 5.33 Million USD | 1329.9% |
| 2016 Q4 | 5.33 Million USD | -0.66% |
| 2016 Q2 | -605.28 Thousand USD | 3.01% |
| 2016 Q3 | 5.37 Million USD | 987.73% |
| 2015 Q1 | 2 Million USD | -12.24% |
| 2015 FY | -434 Thousand USD | -118.97% |
| 2015 Q2 | 864.14 Thousand USD | -56.96% |
| 2015 Q4 | -434 Thousand USD | -169.78% |
| 2015 Q3 | 621.93 Thousand USD | -28.03% |
| 2014 Q1 | 3.36 Million USD | -1.87% |
| 2014 FY | 2.28 Million USD | -33.35% |
| 2014 Q3 | 3.08 Million USD | -5.36% |
| 2014 Q4 | 2.28 Million USD | -25.89% |
| 2014 Q2 | 3.26 Million USD | -3.17% |
| 2013 Q4 | 3.43 Million USD | -3.82% |
| 2013 FY | 3.43 Million USD | -3.68% |
| 2013 Q1 | 3.57 Million USD | 0.31% |
| 2013 Q2 | 3.65 Million USD | 2.29% |
| 2013 Q3 | 3.56 Million USD | -2.41% |
| 2012 Q3 | 3.71 Million USD | 5.17% |
| 2012 Q4 | 3.56 Million USD | -4.06% |
| 2012 Q2 | 3.53 Million USD | -3.07% |
| 2012 Q1 | 3.64 Million USD | 5.15% |
| 2012 FY | 3.56 Million USD | 2.85% |
| 2011 Q2 | 6.76 Million USD | 11.63% |
| 2011 FY | 3.46 Million USD | -37.76% |
| 2011 Q4 | 3.46 Million USD | 5.68% |
| 2011 Q3 | 3.27 Million USD | -51.51% |
| 2011 Q1 | 6.05 Million USD | 8.81% |
| 2010 Q4 | 5.56 Million USD | 7.24% |
| 2010 Q1 | 4.31 Million USD | 17.88% |
| 2010 FY | 5.56 Million USD | 52.17% |
| 2010 Q3 | 5.19 Million USD | 7.33% |
| 2010 Q2 | 4.83 Million USD | 12.15% |
| 2009 Q3 | 5.5 Million USD | 3.46% |
| 2009 Q2 | 5.31 Million USD | 628.02% |
| 2009 Q1 | -1 Million USD | 0.59% |
| 2009 FY | 3.65 Million USD | 461.2% |
| 2009 Q4 | 3.65 Million USD | -33.49% |
| 2008 Q1 | -1.63 Million USD | 1.21% |
| 2008 Q3 | -1.1 Million USD | 26.3% |
| 2008 Q4 | -1.01 Million USD | 8.33% |
| 2008 FY | -1.01 Million USD | 38.72% |
| 2008 Q2 | -1.49 Million USD | 8.18% |
| 2007 Q4 | -1.65 Million USD | 5.05% |
| 2007 Q3 | -1.74 Million USD | -6.04% |
| 2007 FY | -1.65 Million USD | 0.0% |
| 2007 Q2 | -1.64 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | -22.254% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -8268.131% |
| Polarean Imaging plc | -5.94 Million USD | 404.817% |
| Avitar, Inc. | 5.17 Million USD | -250.522% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 3091.096% |
| AVITA Medical, Inc. | -26.23 Million USD | 169.1% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 259043.443% |
| Össur hf. | 395.08 Million USD | 95.412% |
| Zecotek Photonics Inc. | 2.76 Million USD | -556.158% |
| QHSLab, Inc. | 1.72 Million USD | -947.766% |
| Wellstar International, Inc. | 51.36 Million USD | 64.713% |
| Össur hf. | 395.08 Million USD | 95.412% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 492.579% |
| Escalon Medical Corp. | 315.68 Thousand USD | -5641.794% |
| Aurora Spine Corporation | 1.9 Million USD | -850.174% |
| BrainsWay Ltd. | -10.32 Million USD | 275.64% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | -650.553% |
| Vivos Inc. | -1.59 Million USD | 1238.365% |
| MicroPort Scientific Corporation | 673.58 Million USD | 97.309% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -3619.436% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 3450.556% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -2731.322% |
| Nanomix Corporation | 11.38 Million USD | -59.152% |
| Theraclion SA | -5.86 Million EUR | 409.079% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | -354.802% |
| Positron Corporation | 1.68 Million USD | -974.531% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -1025.253% |
| Lombard Medical, Inc. | 11.49 Million USD | -57.686% |
| ALR Technologies Inc. | 19.14 Million USD | 5.338% |
| Stratec SE | 119.12 Million USD | 84.784% |
| Vycor Medical, Inc. | 1.05 Million USD | -1621.442% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -32859.434% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -19349.794% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 231.469% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 39.874% |
| VMS Rehab Systems, Inc. | 133.52 USD | -13575425.015% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -1135.586% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -2772.958% |
| Odyssey Group International, Inc. | 2.1 Million USD | -759.953% |
| United American Healthcare Corporation | -9.32 Million USD | 294.339% |
| ECGI Holdings, Inc. | 3.17 Million USD | -471.575% |
| Capital Group Holdings, Inc. | -3508.00 USD | 516805.844% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -6802.056% |
| Urologix, Inc. | 4.61 Million USD | -292.764% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -330.606% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -444.122% |
| SS Innovations International, Inc. | 1.18 Million USD | -1429.179% |
| Qualis Innovations, Inc. | 6671.00 USD | -271614.001% |
| Smith & Nephew plc | 2.77 Billion USD | 99.348% |
| NIOX Group Plc | -23.93 Million USD | 175.739% |
| Fuse Medical, Inc. | 1.75 Million USD | -932.532% |
| Broncus Holding Corporation | -81.42 Million USD | 122.261% |
| Brain Scientific Inc. | 2.11 Million USD | -756.711% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 20.069% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -45722.588% |